Competing for the treasure in exceptions

MeSH terms

• Drug Approval / legislation & jurisprudence
• Economic Competition
• Enzyme Replacement Therapy
• Gaucher Disease / drug therapy*
• Gaucher Disease / enzymology
• Gaucher Disease / genetics
• Glucosylceramidase / deficiency*
• Glucosylceramidase / economics
• Glucosylceramidase / genetics
• Glucosylceramidase / pharmacology
• Glucosylceramidase / therapeutic use
• Humans
• Randomized Controlled Trials as Topic
• Recombinant Proteins / economics
• Recombinant Proteins / pharmacology
• Recombinant Proteins / therapeutic use
• United States
• United States Food and Drug Administration